Hedge funds significantly increased bearish bets against Hims & Hers Health in January, just weeks before the online healthcare provider became embroiled in a legal and regulatory dispute with Novo Nordisk, according to a report by Reuters citing data from Hazeltree.
Short interest in Hims reached its highest level in at least a year, with nearly 65% of the company’s available shares on loan for short selling during January. The figure marked the most elevated level since October 2025, based...
Continue Reading
Sign up for FREE to read the full article and access 148K+ alternative investment headlines.
Alternative Investment News